Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 27,575 | N/A | N/A |
| Depreciation Amortization | 3,651 | N/A | N/A |
| Accounts receivable | -2,076 | N/A | N/A |
| Accounts payable and accrued liabilities | -954 | N/A | N/A |
| Other Working Capital | -7,848 | N/A | N/A |
| Other Operating Activity | -55,551 | 0 | 0 |
| Operating Cash Flow | $-35,203 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 18,127 | N/A | N/A |
| PPE Investments | -2,536 | N/A | N/A |
| Investing Cash Flow | $15,591 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 25,000 | N/A | N/A |
| Debt Repayment | -142 | N/A | N/A |
| Common Stock Issued | 992 | N/A | N/A |
| Other Financing Activity | -613 | 0 | 0 |
| Financing Cash Flow | $25,237 | $N/A | $N/A |
| Beginning Cash Position | 8,830 | N/A | N/A |
| End Cash Position | 14,455 | N/A | N/A |
| Net Cash Flow | $5,625 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -35,203 | N/A | N/A |
| Capital Expenditure | -2,539 | N/A | N/A |
| Free Cash Flow | -37,742 | 0 | 0 |